Jim Cramer Recommends Eli Lilly Over Viking Therapeutics

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks Jim Cramer was asked about. Mentioning that they are a long-term shareholder of VKTX, a caller said that they have been observing the bidding war between Novo Nordisk and Pfizer for Metsera. Cramer commented:

“Yeah, I know, and I’ve watched that, and I don’t, I think that Viking would’ve gotten a bid if it didn’t get it yet. I know people are expecting whoever loses in that war that you just mentioned is going to buy Viking. I tell you what, you should buy. You own Eli Lilly. That’s been the winner. The trust owns it. I really like it a lot.”

Source: Unsplash

Viking Therapeutics, Inc. (NASDAQ:VKTX) is a clinical-stage biopharmaceutical company developing therapies for metabolic and endocrine disorders. During the lightning round of September 4, a caller asked about the stock, and Cramer said:

“No, no, no. We have Eli Lilly. Why do we have to settle? Let’s, don’t, don’t go for the raggedy rest. Let’s go for the best.”

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.